The predictive value of 18 and 22 week uterine artery Doppler in patients with low first trimester maternal serum PAPP-A

Prenatal Diagnosis

Volumn 29, Issue 3, 2009, Pages 248-252

  Cooper, Stephanie ^a,b   Johnson, Jo Ann M ^a   Metcalfe, Amy ^a   Pollard, Jeffery ^a   Simrose, Rebecca ^a   Connors, Gregory ^a   Jones, Donna ^a   Roggensack, Anne ^a   Krause, Richard ^a   Lange, Ian ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

PAPP A; Prenatal screening; Uterine artery Doppler

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTERVENTION STUDY; LOGISTIC REGRESSION ANALYSIS; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL SERUM; OUTCOME ASSESSMENT; PREDICTION; PREGNANCY OUTCOME; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; UTERINE ARTERY;

ALGORITHMS; ARTERIES; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREMATURE BIRTH; PROSPECTIVE STUDIES; PULSATILE FLOW; ULTRASONOGRAPHY, PRENATAL; UTERUS;

EID: 61449132457     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2175     Document Type: Article

References (22)

1. Albaiges G, Missfelder-Lobos H, Kees C, et al. 2000. One stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks gestation. Obstet Gynecol 95: 559-564.
2. Barrett SL, Bower C, Hadlow NC. 2008. Use of the combined first trimester screen results and low PAPP-A to predict risk of adverse fetal outcomes. Prenat Diagn 28: 28-35.
3. Campbell S, Diaz-Recasens J, Griffin DR, et al. 1983. New doppler technique for assessing uteroplacental blood flow. Lancet 1: 675-677.
4. Conover CA, Bale LK, Overgaard MT, et al. 2004. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131: 1187-1194.
5. Dugoff L, Hobbins JC, Malone FD, et al. 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 19: 1446-1451.
6. Irwin JC, Suen LF, Martina NA, Mark SP, Giudice LC. 1999. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 14(Suppl 2): 90-96.
7. Khong TY, De Wolf F, Robertson WB, Brosens I. 1986. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br JObstet Gynaecol 93: 1049-1059.
8. Krantz D, Goetzl L, Simpson JL, et al. 2004. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191: 1452-1458.
9. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. 1994. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 10: 669-674.
10. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. 2000. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 107: 1265-1270.
11. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH, Fetal Medicine Foundation Second Trimester Screening Group. 2001. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 18: 441-449.
12. Reproductive Health Working Group. 2007. Alberta Reproductive Health: Pregnancies and Births. Alberta Health and Wellness: Edmonton.
13. Smith GC, Shah S, Crossley JA, et al. 2006. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 107: 161-166.
14. SOGC. 2001. Content of a complete obstetrical ultrasound. J Soc Obstet Gynecol Can 23: 427-428.
15. SOGC. 2008. Diagnosis, evaluation and management of hypertension in pregnancy. J Obstet Gynaecol Can 30: S1-S52.
16. Spencer K, Bindra R, Cacho AM, Nicolaides KH. 2004. The impact of smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester. Prenat Diagn 24: 169-173.
17. Spencer K, Cowan NJ, Nicolaides KH. 2008. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenatal Diagnosis 28: 7-10.
18. Spencer K, Ong CYT, Liao AWK, Nicolaides KH. 2000. The influence of ethnic origin on first trimester bichemical markers of chromosomal aneuploidy in the first trimester. Prenat Diagn 20: 491-494.
19. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free b-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13: 231-237.
20. Spencer K, Yu CK, Cowans NJ, et al. 2005. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 25: 949-953.
21. Toal M, Keating S, Machin G, et al. 2007. Determinants of adverse perinatal outcomes in high-risk women with abnormal uterine artery Doppler images. Am J Obstet Gynecol 198: 330.
22. Yaron Y, Heifetz S, Ochshorn Y, Levai O, Orr-Urtreger A. 2002. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenatal Diagnosis 22: 778-782.